Teva Pharmaceutical Industries Limited (TEVA) Earnings
|
Expand Research on TEVA
Next EPS Date | 5/8/24 | EPS Growth Rate | +30.0% |
---|---|---|---|
Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +0.8% |
Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/8/24 | Q124 | N/A | $0.52 | N/A | N/A | $3.73B | N/A | N/A | N/A | ||
1/31/24 | Q423 | $1.00 | $0.77 | +$0.23 | $4.46B | $4.02B | N/A | Details | |||
11/8/23 | Q323 | $0.60 | $0.60 | $0.00 | $3.9B | $3.72B | = | Details | |||
8/2/23 | Q223 | $0.56 | $0.53 | +$0.03 | $3.9B | $3.72B | = | Details | |||
5/10/23 | Q123 | $0.40 | $0.55 | -$0.15 | $3.7B | $3.61B | = | Details | |||
2/8/23 | Q422 | $0.71 | $0.71 | $0.00 | $3.9B | $3.88B | = | Details | |||
7/26/22 | Q322 | $0.59 | $0.56 | +$0.03 | $3.91B | $3.78B | Details | ||||
11/3/22 | Q322 | $0.59 | $0.62 | -$0.03 | $3.6B | $3.85B | Details |